Congruencetherapeutics Is A Biotechnology Company Based In Montrealquebeccanadafounded In 2021Thecompany Specializes In Drug Discovery By Combining Protein Dynamicsbiophysicsmachinelearningand Computational Chemistryits Goal Is To Develop Predictivemodels For Diseasepathogenesis And Enhancethesemodels With Speed And Accuracymoving Beyond Traditional Drug Discovery Methods Thecompany Focuses On Creating Novel Small Molecules For Diseases With Significant Unmet Medical Needsparticularly Thoserelated To Protein Misfoldingsuch As Genetic Obesityparkinson S Diseaseand I 1 Antitrypsin Deficiencycongruencetherapeutics Utilizes Its Proprietary Revenira C Discovery Engineto Identify New Allosteric And Cryptic Pockets In Proteinsfacilitating Thevirtual Screening Of Potential Chemical Compoundsthecompany Has Also Established Research Collaborations With Largepharmaceutical Firms To Discover Small Moleculecorrectors For Solid Tumors And Metabolic Diseases
